Skip to main content

Advertisement

Log in

Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord

  • Research Article
  • Published:
Tumor Biology

Abstract

Corticotropin-releasing factor (CRF) serves as a neuromodulator in the hypothalamic-pituitary-adrenal axis, playing an essential role in depression, anxiety, and pain regulation. However, its biological role in bone cancer induced pain has not been investigated. In the present study, we aimed to elucidate the expression and distribution of CRF in spinal cord using a rodent model of bone cancer pain. Our study showed that implantation of Walker 256 mammary gland carcinoma cells into the tibia of rats significantly increased CRF expression in the spinal cord in a time-dependent manner. The upregulated expression of CRF mainly expressed in the superficial dorsal horn of spinal cord. Moreover, immunofluorescence double staining showed that CRF was extensively colocalized with neurons, but hardly with astrocytes or microglia. In addition, intrathecal injection of CRF receptor antagonist (α-helical-CRF) significantly inhibited heat hyperalgesia, mechanical allodynia, and the expression of c-Fos in spinal dorsal horn of bone cancer pain rats. In summary, our study demonstrates that CRF plays an important role in the development and maintenance of bone cancer pain via activation of neurons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Chen L, Zhu L, Wang K, Wang W, Mei XP, Liu T, et al. Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain. Pain Physician. 2013;16:533–46.

    PubMed  Google Scholar 

  2. Gu X, Zheng Y, Ren B, Zhang R, Mei F, Zhang J, et al. Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-alpha expression in a mouse model. Mol Pain. 2010;6:64.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hald A, Hansen RR, Thomsen MW, Ding M, Croucher PI, Gallagher O, et al. Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790. Int J Cancer. 2009;125:1177–85.

    Article  CAS  PubMed  Google Scholar 

  4. Luger NM, Mach DB, Sevcik MA, Mantyh PW. Bone cancer pain: from model to mechanism to therapy. J Pain Symptom Manage. 2005;29:S32–46.

    Article  CAS  PubMed  Google Scholar 

  5. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s–9.

    Article  PubMed  Google Scholar 

  6. Lozano-Ondoua AN, Symons-Liguori AM, Vanderah TW. Cancer-induced bone pain: mechanisms and models. Neurosci Lett. 2013;557(Pt A):52–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981;213:1394–7.

    Article  CAS  PubMed  Google Scholar 

  8. Im E. Corticotropin-releasing hormone and its biological diversity toward angiogenesis. Intest Res. 2014;12:96–102.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Wang L, Goebel-Stengel M, Stengel A, Wu SV, Ohning G, Tache Y. Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery. Brain Res. 2011;1415:34–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Beurel E, Nemeroff CB. Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour. Curr Top Behav Neurosci. 2014;18:67–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yu Y, Liu ZQ, Liu XY, Yang L, Geng XR, Yang G, et al. Stress-derived corticotropin releasing factor breaches epithelial endotoxin tolerance. PLoS One. 2013;8, e65760.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bangasser DA, Kawasumi Y. Cognitive disruptions in Stress-Related psychiatric disorders: A role for corticotropin releasing factor (CRF). Horm Behav. 2015.

  13. Koob GF, Zorrilla EP. Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view. Neuropsychopharmacol. 2012;37:308–9.

    Article  CAS  Google Scholar 

  14. Shippenberg TS, Herz A, Nikolarakis K. Prolonged inflammatory pain modifies corticotropin-releasing factor-induced opioid peptide release in the hypothalamus. Brain Res. 1991;563:209–14.

    Article  CAS  PubMed  Google Scholar 

  15. Lariviere WR, Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain. 2000;84:1–12.

    Article  CAS  PubMed  Google Scholar 

  16. Sekido R, Ishimaru K, Sakita M. Corticotropin-releasing factor and interleukin-1beta are involved in the electroacupuncture-induced analgesic effect on inflammatory pain elicited by carrageenan. Am J Chin Med. 2004;32:269–79.

    Article  CAS  PubMed  Google Scholar 

  17. Song H, Park H, Park G, Kim YS, Lee HK, Jin DH, et al. Corticotropin-releasing factor induces immune escape of cervical cancer cells by downregulation of NKG2D. Oncol Rep. 2014;32:425–30.

    CAS  PubMed  Google Scholar 

  18. Im E. Multi-facets of corticotropin-releasing factor in modulating inflammation and angiogenesis. J Neurogastroenterol Motil. 2015;21:25–32.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–10.

    Article  CAS  PubMed  Google Scholar 

  20. Mao-Ying QL, Zhao J, Dong ZQ, Wang J, Yu J, Yan MF, et al. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem Biophys Res Commun. 2006;345:1292–8.

    Article  CAS  PubMed  Google Scholar 

  21. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88.

    Article  CAS  PubMed  Google Scholar 

  22. Naguib M, Xu JJ, Diaz P, Brown DL, Cogdell D, Bie B, et al. Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. Anesth Analg. 2012;114:1104–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sande TA, Scott AC, Laird BJ, Wan HI, Fleetwood-Walker SM, Kaasa S, et al. The characteristics of physical activity and gait in patients receiving radiotherapy in cancer induced bone pain. Radiother Oncol. 2014;111:18–24.

    Article  PubMed  Google Scholar 

  24. Currie GL, Delaney A, Bennett MI, Dickenson AH, Egan KJ, Vesterinen HM, et al. Animal models of bone cancer pain: systematic review and meta-analyses. Pain. 2013;154:917–26.

    Article  PubMed  Google Scholar 

  25. Krohg K, Hageman I, Jorgensen MB. Corticotropin-releasing factor (CRF) in stress and disease: a review of literature and treatment perspectives with special emphasis on psychiatric disorders. Nord J Psychiatry. 2008;62:8–16.

    Article  PubMed  Google Scholar 

  26. Ji G, Neugebauer V. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala. J Neurophysiol. 2007;97:3893–904.

    Article  CAS  PubMed  Google Scholar 

  27. Mousa SA, Bopaiah CP, Richter JF, Yamdeu RS, Schafer M. Inhibition of inflammatory pain by CRF at peripheral, spinal and supraspinal sites: Involvement of areas coexpressing CRF receptors and opioid peptides. Neuropsychopharmacol. 2007;32:2530–42.

    Article  CAS  Google Scholar 

  28. Kim EH, Ryu DH, Hwang S. The expression of corticotropin-releasing factor and its receptors in the spinal cord and dorsal root ganglion in a rat model of neuropathic pain. Anat Cell Biol. 2011;44:60–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Swiergiel AH, Takahashi LK, Kalin NH. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res. 1993;623:229–34.

    Article  CAS  PubMed  Google Scholar 

  30. Stern S, Knoll B. CNS axon regeneration inhibitors stimulate an immediate early gene response via MAP kinase-SRF signaling. Mol Brain. 2014;7:86–93.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge the financial supports by a natural science research project of Jiangsu Province Higher Education Institutions (12KJB320013) and a scientific research fund from Ministry of Health of the People’s Republic of China (W201203).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wen Shen.

Additional information

Hou-bao Fan, Ting Zhang and Kai Sun contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, Hb., Zhang, T., Sun, K. et al. Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord. Tumor Biol. 36, 9559–9565 (2015). https://doi.org/10.1007/s13277-015-3670-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3670-1

Keywords

Navigation